Thrilled to see @emma_solly's PhD work published in @Diabetes_ADA. 🎉 @ChrisBursill @sahmriAU Funding: @DiabetesAus & @hosp_research Targeting miR‑181c‑5p restores vascular function in diabetes. 🔗 doi.org/10.2337/db24-0867 #Diabetes #MicroRNA #TranslationalScience

Congratulations to the prize winners and @SACVRN - another great day for the SA cardiovascular research community. Wish I could have made it!

📅 MARK YOUR CALENDAR 📅 The 21st International Symposium on Atherosclerosis is scheduled for October 20-22, 2027 in Santiago, Chile! #ISA2027 will bring together clinicians, scientists, policymakers and patient advocates from across the globe under the theme, "Cardiometabolic Health Unlocked: From Genetics to Global Impact." Thank you to IAS member @ateros_chile for its partnership in co-hosting this event. Look for more information to be released soon! See you in #Santiago!

IAS leadership Dirk Blom, MBChB, PhD, Christina Bursill, PhD, Peter Libby, MD, and Samia Mora, MD, MHS (@SamiaMoraMD), shared their perspective on #WHD and its importance for the #CVD community. #WorldHeartDay

Smiles, cheers, and pure joy 🎉✨ The 2025 World Rowing Masters Regatta in Banyoles is bringing the Rowing family together in true celebration, on and off the water. 💙🚣 #MastersRowing #WRMR2025

Congratulations SA Heart ❤️ Foundation CVRN Early Career Research Day 120 participants!!! and amazing science from our rising stars…SAGreat! @SAHMRI_Heart @heartfoundation @SAHeartStroke @SAHealth @Flinders @thecsanz

🤩 If you haven't already, check out this study where Dr. Primer and researchers at @UniofAdelaide explore the role of the PDK4/PDC axis in angiogenesis, the effect of diabetes on its regulation in response to ischemia, and the proangiogenic properties of rHDL! 👏Congratulations to the team!

Thrilled that our study was featured recently by the media as we continue to unravel the beneficial effects of good cholesterol as a new treatment for diabetic wounds. Fun fact: the study that started it all also received media interest in 2016. @ChrisBursill @Khal1a 👩🏻‍🔬🔬🧫

Well done @Khal1a and team for completing this project that has revealed important new pathways for promoting wound healing in people with diabetes. @adelaideuni @SAHMRI_Heart @jotan80

So excited that this work from my PhD at @sahmriAU is contributing to steps towards new therapies for diabetic wound healing. Can't wait to see where my beloved PDK4 project goes next ❤️ @ChrisBursill @jotan80

1. If #monoclonal #antibodies targeting #IL-1β reduce cardiovascular events but also suppress the immune response, it is indisputable that therapy with NPs targeting #plaque #macrophages will spell the end of atherosclerosis!.... 🐁🔬🤔🤔🙏 2. Will #simvastatin-loaded rHDL NPs and their dramatic effect on plaque macrophages spell the end of #conventional #statins?..🤔🐁🙏🤓🧬 3. Will the definitive solution to #atherosclerotic plaque formation lie in the #genetic #editing of #KLF4 together with #miR143/ #miR145, thereby achieving downregulation of #myocardin and #foam #cell #differentiation?..🤔🔬🐁🙏🧬 @SACVRN @JACCJournals @JAHA_AHA @japplphysiol @ESC_Journals @CTRC_UofSCSOM @AHAScience @society_eas @atherosociety @ESMicro_EU @atvbahajournals @ATVBCouncil @HaoYin20 @Ahmed43101178 @CMPLPUCCHILE @BMVBSoc @SocFisiolChile @ALACFdifusion @IJMS_MDPI @AlisaAn46097029 @APSPhysiology @BloodJournal @LuisSobrevia2 @NatureNano @FacMedicinaUC @ISCPcardio @BritPharmSoc 👇🧵👇😊

Could we inhibit the enzymatic action of #sialidases on #Neu5Ac and thus prevent #LDL #oxidation and #atherosclerosis in the future? Will #gene #editing of #NEU1 and #NEU3 with #CRISPR-Cas9 #technology be the precision treatment for atherogenesis and #CAD in the future? Could #ASGR1 expression levels be the best #predictor of CAD in the future, above #lipid #profiles and non-modifiable factors? @AHAScience @AlisaAn46097029 @IJMS_MDPI @CNIC_CARDIO @Ahmed43101178 @APSPhysiology @AsAshraf123321 @ASH_hematology @atheroaussie @society_eas @ATHjournal @atvbahajournals @ATVBCouncil @CMPLPUCCHILE @LuisSobrevia2 @BloodJournal @BMVBSoc @ChrStaehr @HaoYin20 @ESMicro_EU @The_MCSociety @JAHA_AHA @JACCJournals @japplphysiol @FacMedicinaUC @SocFisiolChile @secardiologia @physoc @ElsevierConnect @CircRes @ajpheartcirc @CircAHA 👇🧵👇🧵🧵 ✌️✌️

Check out our new paper in @atvbahajournals Many thanks to the amazing efforts of @Khal1a @jotan80 and Lauren Sandeman. @UniofAdelaide @sahmriAU @SAHMRI_Heart

Check out our new review on: The emerging role of glycans and the importance of sialylation in cardiovascular disease - @ATHjournal @UniofAdelaide @SAHMRI_Heart atherosclerosis-journal.com/…

By overcoming the limitations of traditional #optics, this #3Dprinted device provides greatly improved imaging capability of high-risk plaques that cause #heartattacks.” doi.org/10.1117/1.AP.7.2.026… #AdvancedPhotonics @SPIEtweets also by @CosmosMagazine cosmosmagazine.com/technolog…

Launching the inaugural Heart Foundation South Australian Kick Start Fellowship for 2025! Elevate ECR careers in cardiovascular researcher in SA. Open now - 24 April heartfoundation.smartsimple.… #EarlyCareerResearchers #HeartFoundation #CardiovascularResearch #SACVRN @OzCvA

Happy 2025 to IAS' international network of atherosclerotic cardiovascular disease experts, their patients and families. #HappyNewYear #2025

The Council of Constituents Societies met on December 6 to vote on a new board of directors for the 2025-2027 term. The International Atherosclerosis Society is proud to announce its new board, effective January 1: 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁: Dirk Blom, MBChB, MMed - South Africa 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁-𝗘𝗹𝗲𝗰𝘁: Samia Mora, MD, MHS - United States 𝗦𝗲𝗰𝗿𝗲𝘁𝗮𝗿𝘆: Viviane Zorzanelli Rocha Giraldez, MD - Brazil 𝗧𝗿𝗲𝗮𝘀𝘂𝗿𝗲𝗿: Jessica Peña, MD, MPH - United States 𝗜𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗣𝗮𝘀𝘁 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁: Peter Libby, MD - United States 𝗘𝗹𝗲𝗰𝘁𝗲𝗱 𝗠𝗲𝗺𝗯𝗲𝗿𝘀 𝗮𝘁 𝗟𝗮𝗿𝗴𝗲: Mutaz Al-Khnifsawi, MD - Iraq Fahad Alnouri, MD, MSc - Saudi Arabia (@AlnouriDr) Christina Bursill, PhD - Australia Ioanna Gouni-Berthold, MD - Germany Jianjun Li, MD, PhD - China Maxima Mendez Castillo, MD - Dominican Republic Manfredi Rizzo, MD, PhD - Italy Banshi Saboo, MBBS, MD - India Shizuya Yamashita, MD, PhD - Japan Congrats to the newly elected board! Let's keep working together toward better prevention and care of atherosclerosis. #ISA2024 #CollaborateForImpact

IAS' Sponsored Symposium is underway at #ISA2024! Come to Hall A to hear from Peter Libby, MD, Christina Bursill, PhD, and Jessica Peña, MD, MPH, FACC, FNLA, on targeting inflammation in residual atherosclerotic risk. Thank you @Novonordisk for sponsoring this session. #CollaborateForImpact

Former AAS President and long time member, @ChrisBursill delivered an excellent talk about the protective role of NRF2 activation in reducing plaque burden and instability #ISA2024